S
Scott M. Lippman
Researcher at University of California, San Diego
Publications - 676
Citations - 66362
Scott M. Lippman is an academic researcher from University of California, San Diego. The author has contributed to research in topics: Cancer & Lung cancer. The author has an hindex of 109, co-authored 651 publications receiving 60987 citations. Previous affiliations of Scott M. Lippman include Cleveland Clinic & Columbia University.
Papers
More filters
Book ChapterDOI
COX-2 inhibitors and other NSAIDs in bladder and prostate cancer.
Book ChapterDOI
Chemoprevention of Aerodigestive Epithelial Cancers
Scott M. Lippman,Waun Ki Hong +1 more
TL;DR: Despite intensified attention to smoking cessation programs, tobacco continues to be a major public health problem throughout the world and directly relates to the magnitude of tobacco use.
Journal ArticleDOI
Inflammation-related genetic variations and survival in patients with advanced non-small cell lung cancer receiving first-line chemotherapy.
Xia Pu,Michelle A.T. Hildebrandt,Charles Lu,Jack A. Roth,David J. Stewart,Yang Zhao,Rebecca S. Heist,Yuanqing Ye,David W. Chang,Li Su,John D. Minna,Scott M. Lippman,Margaret R. Spitz,David C. Christiani,Xifeng Wu +14 more
TL;DR: A strong cumulative effect on overall survival was observed for these SNPs, suggesting genetic variations in inflammation‐related genes could have potential to complement prediction of prognosis.
Journal ArticleDOI
Molecular inimitability amongst tumors: implications for precision cancer medicine in the age of personalized oncology.
Sandip Pravin Patel,Maria Schwaederle,Gregory A. Daniels,Paul T. Fanta,Richard Schwab,Kelly A. Shimabukuro,Santosh Kesari,David Piccioni,Lyudmila Bazhenova,Teresa Helsten,Scott M. Lippman,Barbara A. Parker,Razelle Kurzrock +12 more
TL;DR: It is suggested that most advanced tumors are molecular singletons within and between histologies, and that tumors that differ in histology may still nonetheless exhibit identical molecular portraits, albeit rarely.
Journal ArticleDOI
Chemoprevention of upper aerodigestive tract cancers: a report of the third Upper Aerodigestive Cancer Task Force workshop.
TL;DR: The third workshop in this series focused on the rapidly expanding area of chemoprevention of upper aerodigestive epithelial cancers, with discussion of in vitro and animal‐model data documenting the multistep process of squamous differentiation and carcinogenesis, associated molecular and biochemical alterations, and modulation byChemopreventive agents.